No Data
Idemitsu Kosan, Sumitomo Osaka Cement, etc. (additional) Rating.
Upgraded - bullish code stock name brokerage firm previous change after----------------------------------------------------------<9468>KADOKAWA Macquarie "Neutral" "Outperform" <5233> Taiheiyo Cement Daiwa "2" "1" target stock price change code stock name brokerage firm previous change after----------------------------------------------
Anticancer drug "Tasfigo tablet 35mg" (generic name: Tasulugratinib hydrochloride)
On November 20, 2024, Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) announced today the launch of the selective tyrosine kinase inhibitor for fibroblast growth factor receptor (FGFR), "Tasufigo Tablets 35mg" (generic name: Tasugratinib Succinic Acid Salt) in japan for the indication of "unresectable biliary cancer with FGFR2 fusion gene positive that has worsened after cancer chemotherapy." This drug will be available starting September 24, 2024.
The drug "Rozeparamin 25mg for intramuscular injection", newly launched in japan for amyotrophic lateral sclerosis.
On November 20, 2024, Eisai Co., Ltd. (Headquarters: Tokyo, Representative Executive Officer/CEO: Haruo Naito) today announced that it has newly launched the drug "Rozewalamine Muscle Injection 25mg" (generic name: Mecobalamin) for amyotrophic lateral sclerosis (ALS) in Japan for the indication of "inhibition of progression of functional impairment in ALS". This drug obtained manufacturing and marketing approval on September 24, 2024, and today it has been listed for reimbursement. The approval of this drug was obtained at a national university.
Nikkei average sharply declines, weighed down by the fall of tech stocks.
Last weekend in the USA market, Dow Inc. closed at 43,444.99 points, down 305.87 dollars, while NASDAQ ended trading at 18,680.12 points, down 427.53 points. The selling pressure continued in response to the hawkish remarks of Federal Reserve Chair Powell, leading to a decline after the opening. Buying interest, fueled by expectations of policies supporting corporate performance such as regulatory easing under the upcoming Trump administration, paused, and the speculation of an additional rate cut in December receded following statements from FRB officials, resulting in further declines. The US stocks that fell.
JP Movers | M3 Rose 5.64%, Leading Nikkei 225 Components, Disco Topped Turnover List
Market sentiment was stable today as Nikkei 225 components continued to trade sideways, with M3(2413.JP) being the top gainer today, rising 5.64% to close at 1320.0 yen. In addition, the top loser was Dentsu Group(4324.JP)，falling 10.01% to end at 3687.0 yen.
Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early Alzheimer's Disease
No Data
No Data